» Articles » PMID: 38671993

Transcriptional Responses of Different Brain Cell Types to Oxygen Decline

Overview
Journal Brain Sci
Publisher MDPI
Date 2024 Apr 27
PMID 38671993
Authors
Affiliations
Soon will be listed here.
Abstract

Brain hypoxia is associated with a wide range of physiological and clinical conditions. Although oxygen is an essential constituent of maintaining brain functions, our understanding of how specific brain cell types globally respond and adapt to decreasing oxygen conditions is incomplete. In this study, we exposed mouse primary neurons, astrocytes, and microglia to normoxia and two hypoxic conditions and obtained genome-wide transcriptional profiles of the treated cells. Analysis of differentially expressed genes under conditions of reduced oxygen revealed a canonical hypoxic response shared among different brain cell types. In addition, we observed a higher sensitivity of neurons to oxygen decline, and dissected cell type-specific biological processes affected by hypoxia. Importantly, this study establishes novel gene modules associated with brain cells responding to oxygen deprivation and reveals a state of profound stress incurred by hypoxia.

References
1.
Hubbi M, Semenza G . Regulation of cell proliferation by hypoxia-inducible factors. Am J Physiol Cell Physiol. 2015; 309(12):C775-82. PMC: 4683214. DOI: 10.1152/ajpcell.00279.2015. View

2.
Manella G, Aviram R, Bolshette N, Muvkadi S, Golik M, Smith D . Hypoxia induces a time- and tissue-specific response that elicits intertissue circadian clock misalignment. Proc Natl Acad Sci U S A. 2019; 117(1):779-786. PMC: 6955294. DOI: 10.1073/pnas.1914112117. View

3.
Druker J, Wilson J, Child F, Shakir D, Fasanya T, Rocha S . Role of Hypoxia in the Control of the Cell Cycle. Int J Mol Sci. 2021; 22(9). PMC: 8124716. DOI: 10.3390/ijms22094874. View

4.
Li F, Qiao Z, Duan Q, Nevo E . Adaptation of mammals to hypoxia. Animal Model Exp Med. 2022; 4(4):311-318. PMC: 8690989. DOI: 10.1002/ame2.12189. View

5.
Semenza G . Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012; 33(4):207-14. PMC: 3437546. DOI: 10.1016/j.tips.2012.01.005. View